Passage Bio (PASG)CFO sold ~$38K

~$38K

Approx. value · 2,062 sh @ $18.44

5,402

Holds after · shares reported

Traded

Jan 8, 2026

Filed

Jan 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Nov 10, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
2. Jan 8, 2026 · this disclosureInsiderCFO sold ~$38K of PASG shares in the open market

What came next

1. Jan 8, 2026InsiderCEO sold ~$75K of PASG shares in the open market
2. Jan 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
3. Mar 3, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
4. Mar 4, 2026Company filing · Form 8-K · Agreement endedEnded an important agreement
5. Apr 28, 2026Company filing · Form 8-K · RestructuringAnnounced job cuts, closures or a restructuring“As part of its previously announced efforts to review strategic alternatives to maximize shareholder value, on April 28, 2026, Passage Bio, Inc. (the “ Company ”) announced a restructuring of its workforce (the “ Restructuring Plan ”) to decrease its operating expenses by reducing the workforce by approximately 75%.”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Passage Bio

OQRO holds no insider, Congress, fund or contract record for Passage Bio dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PASG page.

Other recent filings by Kathleen Borthwick, CFO

• SEC Form 4 at Passage Bio (PASG)Feb 12, 2025

The full history of Kathleen Borthwick, CFO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Passage Bio

• SEC Form 4Jun 30, 2026
• SEC Form 4Jan 13, 2026
• SEC Form 4Sep 16, 2025
• SEC Form 4Sep 16, 2025
• SEC Form 4Sep 16, 2025
• SEC Form 4Jul 24, 2025

Everything OQRO holds on this company is on its PASG page.